Delivery Order SPE2DE21D7009-SPE2D626F71HM
- Not listed
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a delivery order valued at $36,589.22 on September 9, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of September 19, 2025, and is being performed in Valencia, California. The award carries no set-aside designation, indicating open competition in the federal marketplace. The contract is funded through the Medical...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $36,654.68 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has an ultimate completion date of December 29, 2025 and will be performed in Valencia, California. The award is issued under a larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop Support Medical...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a delivery order valued at $41,430.34 for pain management medical devices and services. This fixed-price contract with economic price adjustment was awarded on September 9, 2025, with an ultimate completion date of September 19, 2025, and will be performed in Valencia, California. The award carries no set-aside designation, allowing the company to compete openly in the federal marketplace....
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $31,771.22 fixed-price delivery order (Contract No. 4570331497) on December 15, 2025, for pain management medical devices and related services. The award carries an economic price adjustment clause and is scheduled for completion by December 29, 2025. This delivery order was issued under the company's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop Support...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $1,867 fixed-price delivery order with economic price adjustment on September 9, 2025, for pain management medical devices. The contract is set to be completed by September 16, 2025, with performance taking place in Valencia, California. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $26,980 delivery order on November 28, 2025, for pain management medical devices and services. The contract, which carries a fixed-price structure with economic price adjustment provisions, is scheduled for completion by December 5, 2025, and will be performed in Valencia, California. This delivery order was issued without a set-aside designation and is funded through the Defense Department's...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a delivery order valued at $1,825.75 for pain management medical devices under a fixed-price contract with economic price adjustment. The award was issued on May 8, 2025, with an ultimate completion date of May 16, 2025, and will be performed in Valencia, California. This delivery order is issued under the company's larger indefinite delivery contract with the Defense Logistics Agency Troop...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,877.20 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of December 29, 2025, and will be performed in Valencia, California. The award carries no small business set-aside designation and is funded by the Medical Supply Chain, a defense-related procurement entity...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, received a delivery order award valued at $1,891.76 on December 19, 2025, for pain management medical devices and services. The contract is a fixed-price delivery order with economic price adjustment provisions, with an ultimate completion date of December 29, 2025. Work will be performed in Valencia, California. This delivery order is issued under the company's larger indefinite delivery contract with the Defense...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a fixed-price delivery order valued at $43,709.82 on December 15, 2025, for pain management medical devices and equipment. The delivery order, with a ultimate completion date of December 22, 2025, will be performed in Valencia, California, and is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-related procurement entity within the Department of Defense. This award carries no small...
- SPE2DE21D7009Indefinite Delivery Contract
- SPE2DE21D7009-SPE2D626F71HMDelivery Order
Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $2,681.80 on December 19, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has an ultimate completion date of March 2, 2026, and will be performed in Valencia, California. The award carries no small business set-aside designation and is funded through the Medical Supply Chain, a defense-related procurement entity within the Department of Defense. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite delivery contract with the Defense Logistics Agency Troop Support Medical branch, valued at approximately $83.1 million through August 16, 2026. The company specializes in non-opioid pain management solutions for service members and veterans, providing advanced neuromodulation technologies including spinal cord stimulation systems, implantable pain pumps, and radiofrequency ablation devices. These products support military treatment facilities and Veterans Affairs medical centers nationwide, enabling the delivery of sophisticated pain management solutions as an alternative to opioid-based therapies for managing chronic pain resulting from service-related injuries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 12/18/25 |